Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea
Clinical trial NCT03271554 · COMPLETED
Trial details
- NCT number
- NCT03271554
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-11-09
- Primary completion
- 2021-05-28
- Enrollment
- 355
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.